As of June 2026, 18 paid clinical trials are recruiting for Pancreatic cancer in Duarte, California. Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Duarte has approximately 570 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Duarte, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Medical Center | Acute Myeloid Leukemia, Myelodysplastic Syndrome, Malignant Solid Neoplasm | 172 |
| City of Hope | Colorectal Cancer, Breast Cancer, Gastric Cancer | 146 |
| City of Hope Comprehensive Cancer Center | Metastatic Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 98 |
| City of Hope National Medical Center | Breast Cancer, Solid Tumor, Acute Myeloid Leukemia | 54 |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma | 12 |
| City of Hope Cancer Center | Advanced Solid Tumors, Breast Cancer, Cervical Cancer | 8 |
| City of Hope - Duarte Cancer Center | HER2 Mutation, Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Non-small Cell Lung Cancer | 6 |
| City of Hope - Duarte | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Anemia, KRAS G12C-mutated Solid Tumors, Lung Cancer | 4 |
| City of Hope Investigational Drug Services (IDS) | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 3 |
| City of Hope Cancer Center (Data collection only) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Beckman Research Institute of City of Hope | Cancer, End of Life, Prostate Cancer | 2 |
| City of Hope Duarte | Advanced Colorectal Cancer, CRC, Colon Cancer | 2 |
| City of Hope National Cancer Center | Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction | 2 |
| IP Address: City of Hope Investigational Drug Services(IDS) | Acute Myeloid Leukemia, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | 2 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Beckman Research Institute of the City of Hope | Prostate Adenocarcinoma | 1 |
| City Of Hope Comprehensive Cancer Center | Advanced Squamous Tumors | 1 |
| City of Hope (Adults and Pediatrics) | Allogeneic Hematopoietic Cell Transplant, Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Lymphoproliferative Disorders | 1 |
| City of Hope - Duarte Main Site | Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis | 1 |
| City of Hope - National Medical Center | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| City of Hope -Duarte Cancer Center | Ductal Carcinoma in Situ | 1 |
| City of Hope Blood Donor Center | Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia | 1 |
| City of Hope Cancer Center (Data Analysis Only) | Cancer, Recurrence, Recurrent | 1 |
| City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center) | Acute Myeloid Leukemia, in Relapse, MDS | 1 |
| City of Hope Comprehensive Cancer Cente | CTCL | 1 |
Recruiting trials in Duarte grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Duarte from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 570 recruiting clinical trials in Duarte, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Duarte compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Duarte include Acute Myeloid Leukemia (26), Breast Cancer (19), Ovarian Cancer (16), Colorectal Cancer (15), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Duarte on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Duarte include City of Hope Medical Center, City of Hope, City of Hope Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Duarte are Cancer & tumors (431), Diabetes & metabolic (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.